Functional genomic methods to study estrogen receptor activity
- PMID: 22588661
- DOI: 10.1007/s10911-012-9254-4
Functional genomic methods to study estrogen receptor activity
Abstract
Estrogen Receptor (ER) is a nuclear receptor that mediates the actions of estrogen and tamoxifen. ER is expressed in a major fraction of human breast cancers. Recently, genomic maps for estrogen- and tamoxifen-ER have been published. Interestingly, estrogen and tamoxifen induce similar genomic interactions and both ligands have been shown to use co-operating factors. The interactions of these co-operating factors within ER regions have impact both on ER-DNA interactions and gene expression regulated by estrogen and tamoxifen. Moreover, the study of chromatin changes induced by these factors has also provided significant insight into our understanding of ER transcriptional regulation. This methods review describes some functional genomic methods to study the influence of both ER ligands and ER co-operating factors. The analysis of protein-DNA interactions and chromatin changes can be explored by using classical and novel methods such as Chromatin Immunoprecipitation (ChIP) or Formaldehyde-Assisted Isolation of Regulatory Elements (FAIRE). This review also explores the properties of each of these methods and the advantages of combining them with high throughput sequencing.
Similar articles
-
Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer.Sci Adv. 2016 Jun 24;2(6):e1501924. doi: 10.1126/sciadv.1501924. eCollection 2016 Jun. Sci Adv. 2016. PMID: 27386569 Free PMC article.
-
Sex hormone receptors in breast cancer.Vitam Horm. 2013;93:99-133. doi: 10.1016/B978-0-12-416673-8.00001-0. Vitam Horm. 2013. PMID: 23810004 Review.
-
Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer.J Natl Cancer Inst. 2004 Jun 16;96(12):926-35. doi: 10.1093/jnci/djh166. J Natl Cancer Inst. 2004. PMID: 15199112
-
Therapeutic targeting in the estrogen receptor hormonal pathway.Semin Oncol. 2004 Feb;31(1 Suppl 3):28-38. doi: 10.1053/j.seminoncol.2004.01.004. Semin Oncol. 2004. PMID: 15052541 Review.
-
The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen.Oncogene. 2004 Mar 4;23(9):1724-36. doi: 10.1038/sj.onc.1207315. Oncogene. 2004. PMID: 14676837
Cited by
-
Loss of progesterone receptor is associated with distinct tyrosine kinase profiles in breast cancer.Breast Cancer Res Treat. 2020 Oct;183(3):585-598. doi: 10.1007/s10549-020-05763-7. Epub 2020 Jul 24. Breast Cancer Res Treat. 2020. PMID: 32710281 Free PMC article.
-
High Throughput Chemical Screening Reveals Multiple Regulatory Proteins on FOXA1 in Breast Cancer Cell Lines.Int J Mol Sci. 2018 Dec 19;19(12):4123. doi: 10.3390/ijms19124123. Int J Mol Sci. 2018. PMID: 30572598 Free PMC article.
-
Estrogen Receptors: New Directions in the New Millennium.Endocr Rev. 2018 Oct 1;39(5):664-675. doi: 10.1210/er.2018-00087. Endocr Rev. 2018. PMID: 29901737 Free PMC article. Review.
-
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles.Sci Rep. 2018 May 9;8(1):7434. doi: 10.1038/s41598-018-25308-9. Sci Rep. 2018. PMID: 29743643 Free PMC article.
-
CTCF modulates Estrogen Receptor function through specific chromatin and nuclear matrix interactions.Nucleic Acids Res. 2016 Dec 15;44(22):10588-10602. doi: 10.1093/nar/gkw785. Epub 2016 Sep 15. Nucleic Acids Res. 2016. PMID: 27638884 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical